Skip to main content
. 2007 Dec 5;7:135. doi: 10.1186/1471-213X-7-135

Table 2.

Development of CA groups in nr4a2, nr4a2a and nr4a2b morphants.

MOnr4a2 + MOp53

MOnr4a2
72hpf
MOnr4a2a
72hpf
MOnr4a2b
72hpf
MOnr4a2
96hpf
72 hpf 96 hpf
vDC group1 normal (23/23) normal (14/17) normal (25/25) normal (28/28)* normal (28/28) normal (30/30)
vDC group3 normal (23/23) normal (17/17) normal (25/25) normal (28/28) normal (28/28) normal (30/30)
posterior vDC normal (23/23) normal (17/17) normal (25/25) normal (43/43) normal (28/28) normal (30/30)
PO absent (25/26) absent (16/17) normal (25/25) absent (25/43) reduced (15/43) absent (22/28) absent (19/30)
Pr absent (25/26) absent (17/17) normal (18/25) absent (10/43) reduced (33/43) absent (22/28) reduced (6/28) absent (9/30) reduced (21/30)
ACL absent (25/26) absent (17/17) reduced (16/25) absent (15/43) reduced (28/43) absent (28/28) absent (23/30) reduced (7/30)
OB normal (23/23) n.a. normal (25/25) normal (43/43) normal (28/28) normal (30/30)
LC normal (26/26) normal (17/17) normal (25/25) normal (43/43) normal (28/28) normal (30/30)
MO normal (26/26) n.a. reduced (15/25) normal (43/43) normal (28/28) normal (30/30)

The numbers in brackets represent the number of morphants that show the respective phenotypes and the total number of analyzed morphants. (n.a. – not analyzed). Notes: (*) morphants with general morphological defects may sometimes form less DA cells. Abbreviations of the different CA groups: ACL, amacrine cell layer; vDC, ventral diencephalic; posterior vDC, ventral diencephalic groups from 2 and 4 to 6; LC, locus coeruleus; MO, medulla oblongata; OB, olfactory bulb; PO, preoptic area; Pr, pretectum.